March 28, 2017
Swiss pharmaceutical giant Novartis scored a partial victory Tuesday when a Delaware federal judge said three drugmakers induced infringement of its patents when they filed abbreviated new drug applications for a generic version of Zortress, a medication used to treat organ transplant recipients.
September 16, 2014
Novartis Pharmaceuticals Corp. hit Roxane Laboratories Inc. with a patent infringement suit in Delaware federal court Tuesday in an effort to block a generic version of Zortress, a medication used to treat organ transplant recipients.